Boston scientific received information that this implantable cardioverter defibrillator (icd) and the patient's right ventricular (rv) lead exhibited noise, oversensing and pacing inhibition of approximately two seconds.The patient was referred to their physician for lead testing.The patient returned to their physician's office, and isometrics were performed which reproduced the noise.The patient was scheduled for a lead revision.No adverse patient effects were reported.The device remains in service.
|